CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 80 enrolled
Drug / intervention
MyPEEPS Mobilebehavioral
Likely dose
Not stated in record
Key inclusion· 8
  • ✓Age 15-25 years
  • ✓Female sex assigned at birth
  • ✓Identify as transgender man or transmasculine spectrum (including transmasculine non-binary)
  • ✓English language literacy
Key exclusion· 3
  • ✕HIV positive status
  • ✕Unable to provide informed consent due to severe mental or physical illness or substance intoxication at enrollment
  • ✕Concurrent enrollment in another HIV prevention study

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05424718
NCT05424718N/ACompleted
CompareCT.gov

MyPEEPS (Male Youth Pursuing Empowerment, Education, and Prevention Around Sexuality) Mobile for Young Transgender Men

Columbia University·interventional·Posted Jun 21, 2022·Updated Mar 11, 2025

In Brief

A clinical study evaluating MyPEEPS Mobile for HIV. Completed, enrolled 80 participants across 3 sites.

Detailed Summary

The proposed MyPEEPS intervention for young transgender men is a novel and evidence-driven intervention using mobile technology to deliver HIV prevention information to high risk youth. The final product will be the basis for conducting a large-scale efficacy study in this population.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH), Ann & Robert H Lurie Children's Hospital of Chicago, Callen-Lorde Community Health Center

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 21, 2022
Enrollment StartJun 16, 2023
Primary CompletionMar 21, 2024
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 4.0 years ago

Interventions

MyPEEPS Mobilebehavioral

Mobile technology to deliver HIV prevention information specifically developed for at-risk young men that have sex with men (YMSM).